{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:22:08Z","timestamp":1772025728194,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jiac.2026.102926","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:21:47Z","timestamp":1770657707000},"page":"102926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of recombinant human thrombomodulin in a pediatric case of COVID-19\u2013associated coagulopathy: A case report"],"prefix":"10.1016","volume":"32","author":[{"given":"Fumihiro","family":"Ochi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-3504","authenticated-orcid":false,"given":"Kozo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Ukita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomozo","family":"Moritani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisamichi","family":"Tauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.102926_bib1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/jamapediatrics.2020.1948","article-title":"Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units","volume":"174","author":"Shekerdemian","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jiac.2026.102926_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2026.102926_bib3","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","article-title":"The coagulopathy of coronavirus disease 2019","volume":"48","author":"Iba","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2026.102926_bib4","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jiac.2026.102926_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.649122","article-title":"Thromboplasminflammation in COVID-19 coagulopathy: three viewpoints for diagnostic and therapeutic strategies","volume":"12","author":"Gando","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jiac.2026.102926_bib6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2026.102926_bib7","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1172\/JCI140970","article-title":"Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2","volume":"130","author":"Diorio","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jiac.2026.102926_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30079","article-title":"COVID-19-associated coagulopathy in children: a multicenter observational cohort study","volume":"70","author":"Zabeida","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jiac.2026.102926_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/138945012799424606","article-title":"Thrombomodulin links coagulation to inflammation and immunity","volume":"13","author":"Morser","year":"2012","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jiac.2026.102926_bib10","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2026.102926_bib11","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/jth.14812","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysis","volume":"18","author":"Valeriani","year":"2020","journal-title":"J Thromb Haemostasis"},{"key":"10.1016\/j.jiac.2026.102926_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104362","article-title":"Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past","volume":"127","author":"Giannis","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jiac.2026.102926_bib13","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/cbin.11623","article-title":"COVID\u201019\u2010related coagulopathy: a review of pathophysiology and pharmaceutical management","volume":"45","author":"Vajari","year":"2021","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jiac.2026.102926_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with COVID-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2026.102926_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1055\/a-1347-6070","article-title":"Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicenter Italian CORIST study","volume":"121","author":"Castelnuovo","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jiac.2026.102926_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10557-020-07133-3","article-title":"The association of low molecular weight heparin use and in-hospital mortality among patients hospitalized with COVID-19","volume":"36","author":"Shen","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jiac.2026.102926_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1177\/1076029614523490","article-title":"Postmarketing surveillance of recombinant human soluble thrombomodulin (thrombomodulin \u03b1) in pediatric patients with disseminated intravascular coagulation","volume":"20","author":"Shirahata","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jiac.2026.102926_bib18","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1213\/ANE.0000000000005059","article-title":"Revisiting the protein C pathway: an opportunity for adjunctive intervention in COVID-19?","volume":"131","author":"Mazzeffi","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jiac.2026.102926_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijid.2021.05.016","article-title":"Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: a systematic review and meta-analysis of adjusted effect estimates","volume":"108","author":"Martha","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2026.102926_bib20","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/bjh.17388","article-title":"Glucocorticoid use and risk of first and recurrent venous thromboembolism: self\u2010controlled case\u2010series and cohort study","volume":"193","author":"Orsi","year":"2021","journal-title":"Br J Haematol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:32:02Z","timestamp":1772022722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1341321X26000243"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102926","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of recombinant human thrombomodulin in a pediatric case of COVID-19\u2013associated coagulopathy: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102926","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102926"}}